Insulet | PODD - Assets


Insulet reported $3.17B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Align Technology USD 6.52B 103.03M Sep/2026
AtriCure USD 676.64M 32.66M Jun/2026
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Cardinal Health USD 57.3B 610M Jun/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
Globus Medical USD 5.49B 48.7M Jun/2026
ICU Medical USD 3.97B 42.48M Jun/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Merit Medical Systems USD 2.92B 61.29M Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Solventum Corp USD 14.24B 146M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 6.79B 3.78M Jun/2026
West Pharmaceutical Services USD 4.06B 15.7M Sep/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026